The 2026 State of Independent Biomedical Equipment Services

Who this is for

You run the truck. You carry the pager. You know which hospital's central sterile department calls at 2am when the sterilizer throws a fault and the OR schedule for the morning is already booked solid. You know which surgery center pays in 30 days and which one needs three reminders. You know the PM schedule for every infusion pump, defibrillator, anesthesia machine, and dialysis station on your route, and you know it because if it slips, the Joint Commission survey finds it and the facility's accreditation takes the hit — not yours, but they remember whose name was on the service log.

This brief is for you — the owner of the independent biomedical equipment service company. The ISO. The shop that competes with the OEM's $300/hour field service rate and wins because you show up the same day and you actually answer the phone.

This is not for the hospital. It's not for the procurement department or the GPO. It's written operator-to-operator, for the person who built a book of preventive-maintenance contracts one handshake at a time and is now wondering what the whole thing is worth — and whether the people circling the industry with checkbooks know something you don't.

Here's what we promise to give you, straight:

1. The numbers — industry size, margins, and what's actually driving demand, with the citations.
2. The consolidation wave — who is buying, what they pay, and a segment the consolidators have largely overlooked.
3. The succession gap — the demographic force quietly setting the price of every shop in this industry.
4. What your company is actually worth — the buyer's real valuation logic, and the five levers that move your number.

Where a figure is a hard data point, we cite it. Where it's an estimate or a range drawn from the data, we say so plainly. We would rather under-claim than have you catch us inflating a number — because if we lose your trust on page two, nothing else in here matters.

Part 1 — The numbers, straight

Industry size. The U.S. market for independent healthcare-equipment maintenance and repair services runs roughly $13.0 billion (2025), growing about +3.0% (2025). That's steady, single-digit, recession-resistant growth — not a hype curve, a utility curve. (Source: Planet's Problems research and analysis, drawing on IBISWorld healthcare-equipment-services data, NAICS roughly 811210 / 532490.)

Margins. This is where the business gets interesting. At a well-run shop:

• EBITDA margins run 25–27% at quality operations.
• Small-shop SDE (seller's discretionary earnings) runs 28–35% — because the owner's salary, truck, phone, and a pile of personal add-backs flow back into the number a buyer cares about.
• Gross margins sit around 50% — your cost is mostly skilled labor and parts, and the labor is billed at a strong multiple.

Those are not retail margins. They are professional-services margins, on work that is legally required to happen.

Demand is mandated — this is the whole point. You don't sell a nice-to-have. The Joint Commission and CMS require documented preventive maintenance on medical equipment. A hospital cannot skip it. A surgery center cannot defer it to next quarter when budgets are tight. The equipment has to be inspected, tested, and certified on a schedule, with paperwork, forever — or the facility risks its accreditation and its Medicare reimbursement.

And here's the part that built this entire independent industry: CMS's Alternative Equipment Maintenance (AEM) program lets a qualified ISO compete head-to-head with the OEM's own service arm. You don't have to be the manufacturer to be allowed to maintain the device. That regulatory opening is the reason a one-master-technician shop can hold contracts against a billion-dollar manufacturer — and win on price and response time.

The labor shortage is the tailwind AND the risk. Roughly 400 BMET (biomedical equipment technician) graduates enter the field per year, against an estimated 7,300 annual openings. (Source: Planet's Problems analysis / BMET workforce data.) That math does not close. It is a permanent, structural shortage of the exact people who do this work.

Read that two ways, because both are true:

• Tailwind: the work cannot be staffed by everyone, so demand for a shop that already has trained, certified techs is durable. The shortage is your moat.
• Risk: the techs are the asset. If you can't replace a tech who leaves, neither can a buyer — which is exactly why your retention practices either make or break your valuation (Part 4).

Put it together: recession-resistant, legally mandated, recurring revenue, professional-services margins, on work nobody can fully staff. That's a rare set of structural facts. Most industries have one of those. This one has all five.

Part 2 — The consolidation wave: who's buying, and at what price

Capital has noticed the top of this industry. It has not yet noticed the bottom. That gap is the entire opportunity, so let's be precise about it.

Who is buying at the top:

• Agiliti — the largest pure-play in medical equipment management and service. It was taken private by Thomas H. Lee Partners (THL) in a deal valued around $2.5 billion. Agiliti buys platforms — companies with $50M+ in revenue. It is not calling your $2M shop.
• TRIMEDX — focused on hospital-system HTM (healthcare technology management) contracts; competes for the big integrated-delivery-network accounts.
• Sodexo HTM — the facilities-services giant's healthcare-technology arm, bundling equipment service into larger hospital contracts.

And one cautionary tale: Avante Health Solutions went bankrupt in 2024. Scale and a roll-up strategy do not guarantee survival in this space. Over-leverage and integration sprawl can sink a big platform as fast as it was assembled. Worth remembering the next time someone tells you "bigger is automatically safer."

Here is the key point — read it twice: nobody is buying the $1–5M independent shops. The small end of this industry is structurally ignored by private equity today. The platforms have a revenue floor and your shop sits below it. The strategics want hospital-system contracts, not a regional book of surgery-center PMs. So the firms that do the actual front-line work — the owner-operated ISOs — sit in a window with almost no institutional buyers competing for them.

Now the multiples, because the spread is the whole story:

• At the platform level, THL paid roughly 9.4x EBITDA for Agiliti — flag this as our research estimate, derived from the reported deal value against estimated earnings, not a figure THL published.
• At the small, owner-dependent end, operator-to-operator deals trade at roughly 1.9x–3.5x SDE. As a sold comp: a Florida shop listed at $240K against $127K SDE — about 1.9x SDE.

Sit with that spread. A small owner-dependent shop changes hands around 2–3.5x SDE. A platform that has assembled those shops, de-risked them, and crossed the $50M line sells around 9x EBITDA. The distance between "small shop ignored today" and "platform sold at 9x tomorrow" is the whole game — and it's available to anyone willing to buy at the bottom, do the un-sexy work of de-risking the asset, and either hold the cash flow or assemble toward the platform multiple.

Part 3 — The succession gap (the force setting your price)

There is a demographic clock running underneath this entire industry, and it is the single biggest force on what your shop will sell for.

Walk the directory of independent ISOs and you'll see the pattern without needing a statistic. Many of these companies were founded by a single master technician in the 1980s or 1990s — the guy who could fix anything, who built the hospital relationships personally, whose certifications and decades of trust are the business. The tell is right on the truck and the website: a founder's surname as the company name, plus "serving hospitals since 19xx." That combination is the succession-gap signal flashing in plain sight.

Here's the imbalance that sets your price:

• More motivated sellers are arriving every year — founders hitting their late 60s and 70s, tired, with no kid who wants to carry the pager.
• Few qualified buyers can actually run a tech-dependent book — because the same labor shortage that protects your revenue makes it hard for any buyer to operate a shop whose value walks out the door if the techs leave.

That imbalance pushes two directions at once. Downward pressure on owner-dependent firms — lots of sellers, few buyers who can run them, so the price gets discounted for the key-man risk. Upward pressure on firms that already run without the founder — those are rare, they're what every buyer actually wants, and they command the top of the range. Which side of that line your company falls on is mostly within your control. That's Part 4.

Part 4 — What your company is actually worth (and the levers that move it)

Forget the rules of thumb you've heard at trade shows. Here is the actual logic a serious buyer runs, in three steps.

Step 1 — Normalize the earnings. The buyer doesn't care about your tax return's bottom line. They rebuild it to SDE (for owner-operated shops) or EBITDA (for larger ones) by adding back the things that are really owner benefit, not business cost: your above-market salary, the personal vehicle, the phone, the "consulting fees" to a relative, the one-time expenses. Clean add-backs raise the number the multiple gets applied to. Sloppy, undocumented add-backs get thrown out — and make the buyer suspicious of everything else.

Step 2 — Set the multiple, which is entirely about risk. The multiple is not a market constant. It's the buyer's read on how likely your cash flow is to survive without you. Here is what they check:

Step 3 — The tech-retention reality, because it defines this asset class. Of everything in that table, tech retention is the one that separates a clean sale from a dead deal. A buyer is not purchasing your trucks — they're purchasing a recurring book that only stays recurring if the credentialed people who service it stay. So a serious buyer will require signed retention agreements with your key techs before close, and they will verify the certifications live — on the STAFF, not on you. If the certs and relationships live only in the owner's head, the buyer is buying a melting ice cube and will price it like one.

A grounded illustration — clearly labeled, this is not a quote, an offer, or an appraisal of any specific company:

Take a $2M-revenue shop with about $500K SDE. Owner-dependent, handshake contracts, concentrated customers. At 3x SDE that's roughly $1.5M.

Now take the same shop, re-engineered: runs without the founder, techs locked under retention agreements, multi-year written PM contracts, customers diversified. That's no longer a key-man risk — it's a platform-quality book. A strategic or PE buyer underwrites toward the higher band, because they can plug it straight into a roll-up without the integration risk that scares them about owner-dependent shops.

Same revenue. Same techs. Same trucks. The difference in price is almost entirely the difference in risk you removed before you went to market.

The five levers — in priority order, this is the work that moves your number:

1. Get yourself out of the wrench. Credential and retain techs who own the customer relationships. The day the business runs without you on the truck is the day it becomes sellable at a real multiple.
2. Paper the contracts. Convert every handshake and verbal renewal into multi-year written PM agreements with clear terms. Written contracts are the asset; relationships in your head are not transferable.
3. Grow the contractually-recurring share. Shift the revenue mix away from one-off repairs toward committed, scheduled PM revenue. Predictable beats large.
4. Diversify the customer base. Get any single customer under ~15% of revenue. Concentration is the fastest way to lose two turns of multiple — or lose the deal entirely.
5. Clean the financials and systematize. Real books, real add-back documentation, work-order software, documented PM schedules. A buyer pays for what they can verify; they discount what they have to take on faith.

Run those five and you don't just raise your multiple — you move your company from the "downward pressure" pile in Part 3 to the "upward pressure" pile. Same business, different price, because you sold them certainty instead of yourself.

Where the data in this brief comes from

We'd rather tell you exactly where each number came from than have you wonder which ones we made up. So, plainly:

• Industry size, growth, margins, and the demand mandate (~$13.0B, +3.0% 2025, 25–27% EBITDA, 28–35% SDE, ~50% gross, Joint Commission / CMS / AEM requirements) — IBISWorld healthcare-equipment-services data (NAICS ~811210 / 532490), compiled in the Planet's Problems research and analysis.
• Buyer names, multiples, and comps (Agiliti / THL ~$2.5B and ~9.4x EBITDA, TRIMEDX, Sodexo HTM, Avante 2024 bankruptcy, the ~1.9x–3.5x SDE small-shop range, the Florida $240K / $127K SDE comp, the ProNova ~37% recurring marker) — comparable-transaction analysis. Where a multiple was not published, we flagged it as a research estimate (the 9.4x Agiliti figure in particular is our estimate derived from reported deal value against estimated earnings, not a THL disclosure).
• Succession and age signals (the ~40%-of-BMETs-55+ figure, the founder-named-company pattern, the rising-sellers / scarce-buyers imbalance) — structural inference from BMET-workforce age data and owner-operated industry patterns. This is explicitly an estimate and a pattern read, not an invented precise statistic. We told you in Part 3 that no clean "% of owners 60+ with no plan" number exists, and we meant it.

If a number in here moves your thinking, verify it against your own books and a real advisor before you act on it. That's not a disclaimer reflex — it's how operators who keep their money behave.

A note from Planet's Problems

What you just read is the kind of intelligence that usually arrives attached to a $5,000 advisory invoice — the industry scan, the buyer map, the valuation logic, the levers. We gave it to you free because we think the people who actually run these businesses deserve to see the board the same way the people with checkbooks see it.

Here's the other thing we do. We record conversations with operators who built real, durable, problem-solving businesses — the founders who took a one-truck repair shop and turned it into a book that hospitals depend on. Not a sales pitch. Not a webinar funnel with an upsell at minute 40. A real conversation, worth recording, about what you built and how.

If you run an independent ISO and you've got a story under the hood, we'd like to talk.

Book an interview →

No obligation, no pitch. Just a conversation worth recording.

This brief is general industry intelligence, not financial, legal, or valuation advice for any specific company. Figures cited are drawn from third-party data and independent analysis; estimates and ranges are labeled as such. Comparable-transaction multiples and the illustrative valuation example are for general education only and are not an offer, a quote, or an appraisal of any business. Before acting on anything here, consult your own accountant, attorney, and a qualified business appraiser. Planet's Problems and Planet's Problems make no warranty as to completeness or accuracy and accept no liability for decisions made in reliance on this material.